Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 and Hepatitis A Vaccine Co-administration in Adults
NCT01926860Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Aug 2013
- Primary completion
- Oct 2019
- Modality
- Split/Subunit Vaccines, Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine, Hepatitis A virus vaccine in pneumococcal infection, hepatitis A (HAV), sponsored by Helsinki University Hospital. Started Aug 2013; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccineHepatitis A virus vaccine
03
Conditions
pneumococcal infectionhepatitis A (HAV)
Beyond the preview
Go deeper on NCT01926860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01926860.